Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v3.21.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Cash flows from operating activities:    
Net income (loss) $ (80,407) $ 216,565
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation, depletion and amortization 70,987 131,463
Amortization of non-cash debt related items, net 2,256 407
Deferred income tax expense 0 64,048
(Gain) loss on derivative contracts 214,523 (251,969)
Cash received (paid) for commodity derivative settlements, net (42,162) 2,613
Non-cash expense (benefit) related to share-based awards 7,608 (2,972)
Other, net 1,217 136
Changes in current assets and liabilities:    
Accounts receivable (45,683) 115,873
Other current assets (2,856) (781)
Accounts payable and accrued liabilities 12,182 (83,688)
Net cash provided by operating activities 137,665 191,695
Cash flows from investing activities:    
Capital expenditures (101,341) (213,459)
Acquisition of oil and gas properties (768) (10,989)
Proceeds from sale of assets 0 10,240
Cash paid for settlements of contingent consideration arrangements, net 0 (40,000)
Other, net 3,595 (158)
Net cash used in investing activities (98,514) (254,366)
Cash flows from financing activities:    
Borrowings on Credit Facility 303,000 4,291,000
Payments on Credit Facility (338,000) (4,226,000)
Other, net (37) (870)
Net cash provided by (used in) financing activities (35,037) 64,130
Net change in cash and cash equivalents 4,114 1,459
Balance, beginning of period 20,236 13,341
Balance, end of period $ 24,350 $ 14,800